Moderna (MRNA) Increasing Global Vaccine Supply

Schwab Network

English - May 06, 2021 16:26 - 6 minutes - 39.4 MB - ★★★★★ - 23 ratings
News Commentary News Business News business news news commentary news Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Twilio (TWLO) Earnings

Next Episode: GMBL CEO On The Esports & Online Gambling Company

Moderna: MRNA earnings report indicated $2.84 in EPS and $1.9B in revenue. The company will supply a Covid-19 booster vaccine to Switzerland. Oppenheimer's Hartaj Singh weighs in and says that they have an outperform rating on the stock with a $206 price target.